Table 2.
Prevalence of PED-PRO-CTCAE Core AEs at T1 (N = 477)
| AE Symptom | N (%) |
|---|---|
| Fatigue | 326 (68.3) |
| Insomnia | 251 (52.6) |
| Pain | 242 (50.7) |
| Nausea | 219 (45.9) |
| Anxiety | 217 (45.5) |
| Abdominal pain | 216 (45.3) |
| Anorexia | 212 (44.4) |
| Headache | 207 (43.4) |
| Depression | 185 (38.8) |
| Constipation | 178 (37.3) |
| Cough | 173 (36.3) |
| Diarrhea | 145 (30.4) |
| Neuropathy | 142 (29.8) |
| Mucositis | 141 (29.6) |
| Vomiting | 107 (22.4) |
| Total number of AEs reported | |
| 0 | 15 (3.1) |
| 1 | 39 (8.2) |
| 2 | 31 (6.5) |
| 3 | 35 (7.3) |
| 4 | 43 (9.0) |
| 5+ | 314 (65.8) |
An AE toxicity was defined “Yes” if any of its attribute (frequency, severity, or interference) scores was ≥1.